Rivaroxaban
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Cardiac & Hypertension treatment.
🧴 Clinical Application
Doses of 15 mg and 20 mg MUST be taken with food/a meal to ensure complete absorption (food increases bioavailability from 66% to near 100%). Doses of 2.5 mg and 10 mg can be taken with or without food. Do not miss doses.
⚠️ Side Effects
Common: Bleeding, epistaxis, hematoma, gastrointestinal hemorrhage, dizziness, headache. Rare/Severe: Boxed warnings: Increased thrombotic events on premature discontinuation; epidural/spinal hematoma with neuroaxial procedures; major fatal hemorrhage.
🛡️ Safety Warnings
Black box warnings for stroke risk upon premature discontinuation and spinal hematoma during epidural procedures. 15 mg and 20 mg tablets must be taken with meals. Contraindicated in active bleeding and clinically significant hepatic disease. Avoid in moderate-to-severe mitral stenosis or mechanical prosthetic heart valves.
Jan Aushadhi Products containing Rivaroxaban
Found 4 generic formulation(s) containing this active ingredient.
Rivaroxaban Tablets 10mg
Rivaroxaban is an oral, direct, and selective competitive factor Xa inhibitor (DOAC) on the WHO Model List of Essential Medicines. By blocking factor Xa, it interrupts both intrinsic and extrinsic coagulation cascades, preventing thrombin generation and clot propagation. Indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), and CAD/PAD risk reduction (in combination with aspirin).
Rivaroxaban Tablets 20mg
Rivaroxaban is an oral, direct, and selective competitive factor Xa inhibitor (DOAC) on the WHO Model List of Essential Medicines. By blocking factor Xa, it interrupts both intrinsic and extrinsic coagulation cascades, preventing thrombin generation and clot propagation. Indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), and CAD/PAD risk reduction (in combination with aspirin).
Rivaroxaban Tablet 15 mg
Rivaroxaban is an oral, direct, and selective competitive factor Xa inhibitor (DOAC) on the WHO Model List of Essential Medicines. By blocking factor Xa, it interrupts both intrinsic and extrinsic coagulation cascades, preventing thrombin generation and clot propagation. Indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), and CAD/PAD risk reduction (in combination with aspirin).
Rivaroxaban Tablet 2.5 mg
Rivaroxaban is an oral, direct, and selective competitive factor Xa inhibitor (DOAC) on the WHO Model List of Essential Medicines. By blocking factor Xa, it interrupts both intrinsic and extrinsic coagulation cascades, preventing thrombin generation and clot propagation. Indicated for stroke prevention in non-valvular atrial fibrillation, treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), and CAD/PAD risk reduction (in combination with aspirin).
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Rivaroxaban.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Rivaroxaban Tablets 10mg | 30's | ₹196.88 | RIVABAN, XARELTO, RIVAFLO, RIVAXA, ROVOR | ₹989.48 | 80% Save |
| Rivaroxaban Tablets 20mg | 14's | ₹140.63 | XARELTO, RIVABAN, RIVAFLO, RIVAXA, RICOSPRIN | ₹518.63 | 73% Save |
| Rivaroxaban Tablet 15 mg | 14's | ₹117.19 | RIVABAN, XARELTO, RIVAFLO, RICOSPRIN, RIVAXA | ₹463.27 | 75% Save |
| Rivaroxaban Tablet 2.5 mg | 14's | ₹42.19 | XARELTO, RICOSPRIN, RIVABAN, RIVAFLO, RIVAXA | ₹203.22 | 79% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Rivaroxaban generics.